(Q59238302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

William David Foulkes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Jonathan Lachapelle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Inti Zlobec

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Tarek A Bismar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Luigi Terracciano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

24 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1107-1116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas--correlation with tumour differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Functional analysis of tumor-infiltrating leukocytes in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

The pathology of familial breast cancer: Morphological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

The immune response to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

The role of CD4 T cell help for CD8 CTL activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tumor immunoediting and immunosculpting pathways to cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tumor-infiltrating T lymphocytes: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tissue microarray technology for high-throughput molecular profiling of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03846.X

10.1111/J.1365-2559.2011.03846.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21707712%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference